The Latest Cardiac and Vascular News
Results of COMPASS Trial Presented at International Stroke Conference LOS ANGELES – Jan. 25, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the presentation of the results of the COMPASS Trial, an independent, prospective, multi-center randomized trial that showed the use of […]
ARISE II Clinical Trial Results Presented at International Stroke Conference LOS ANGELES – Jan. 25, 2018 – EMBOTRAP® Device, a device designed to remove clots from the brain following an ischemic stroke, demonstrated high success rates in restoring blood flow and patients achieved high rates of functional independence, according to […]
KALAMAZOO, Michigan, USA, Jan. 25, 2018 /PRNewswire/ — Yesterday the American Heart Association and American Stroke Association updated the ischemic stroke guidelines. The new recommendation expanded the treatment window from six to 16 hours based on overwhelming clinical evidence from the Stryker-sponsored DAWN Trial and confirmed by DEFUSE 3. The guidelines state that […]
IRVINE, CA – Jan. 24, 2018 – CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, today announced the launch of the GALAXY G3 MINI Coil, its smallest and softest embolic finishing coil, for use in the endovascular treatment of cerebral aneurysms and hemorrhagic stroke. The company received 510 […]
Results of the PROMISE Study Presented at International Stroke Conference LOS ANGELES – January 25, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced results of the company-sponsored PROMISE Study, demonstrating real-world safety and efficacy of the Penumbra System with ACE™68 and ACE™64 […]
EDEN PRAIRIE, Minn., Jan. 23, 2018 /PRNewswire/ — MIVI Neuroscience, a company dedicated to developing best-in-class treatment solutions to improve clinical outcomes for stroke patients, today announced that Bob Colloton has joined the company’s senior management team as Chief Commercial Officer. Bob brings 27 years of proven experience in medical device sales and market development […]
ALAMEDA, Calif. – January 17, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced key events at the upcoming International Stroke Conference 2018 meeting (ISC 2018) to be held January 24-26 at the Los Angeles Convention Center. These events include results from two […]
DUBLIN – January 16, 2018 – Medtronic plc (NYSE:MDT) today announced that the company’s Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio. The Riptide Aspiration System is designed to retrieve thrombus […]
PLEASANTON, Calif., Jan. 4, 2018 /PRNewswire/ — Cerebrotech Medical Systems, an innovative medical device company developing neurotechnology solutions, has received clearance from the Food and Drug Administration, or FDA, for the Cerebrotech Visor, previously known as the CMS-5000™ Intracranial Fluids Monitor™. The clearance includes a broad indication for use as an aid in the […]
Robocath receives an additional €1.25 million financial contribution from Crédit Agricole Innovations et Territoires (CAIT), an innovation fund managed by Supernova Invest. In line with the company’s growth strategy, the new funding aims to increase the resources available to market the R-OneTM product and launch the development of the next generation of […]
